A-Alpha Bio logo

A-Alpha Bio

aalphabio.com

A-Alpha Bio develops biotechnology platforms that use synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions. Its AlphaSeq platform enables rapid, quantitative measurement of millions of protein binding affinities, while AlphaBind predicts binding strength from sequence using a large protein interaction database. The company partners with pharmaceutical organizations and runs in-house therapeutic programs to support the discovery and development of novel medicines.

Facts

HQ
Seattle
Sectors
Biotechnology Research
Founded
2017
Type
Corporation Seattle business license
Employees
50
Registered name
A Alpha Bio Inc Seattle business license
Stage
Series A
Members see funding amounts.
.
Founders
David Younger, PhD, Randolph Lopez, PhD

Is this your organization? Claim it

Recent coverage

Front-page news, podcasts and videos about A-Alpha Bio

See all 56

Harell Data Raises $15M to Reward Data Generators and Speed AI Drug Discovery, Founder Harlan Robins Launches New Cloud Service

Harell Data, founded by Harlan Robins, raised $15 million to build a cloud platform that better rewards data generators and accelerates AI-driven drug discovery by hosting proprietary, well-curated datasets and secure GPU compute. The service partners with CoreWeave and initial data contributors like A-Alpha Bio to provide datasets for model builders while creating revenue-sharing incentives for those who produce the data.

People

  • David Younger
    David Younger Executive Officer, Director, Chief Executive Officer & Co-Founder
  • Randolph Lopez Chief Technology Officer & Co-Founder

Online

Questions about A-Alpha Bio

What is A-Alpha Bio?

A-Alpha Bio is a biotechnology startup based in Seattle that uses synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions. The company partners with pharmaceutical organizations and runs in-house therapeutic programs to support medicine discovery and development.

What is A-Alpha Bio known for?

A-Alpha Bio develops AlphaSeq, a platform for quantitative measurement of protein binding affinities, and AlphaBind, which predicts binding strength from sequence using a protein interaction database.

Who are the people behind A-Alpha Bio?

Seattle Flow lists David Younger (Executive Officer, Director, Chief Executive Officer & Co-Founder) and Randolph Lopez (Chief Technology Officer & Co-Founder) at A-Alpha Bio.

Who invested in A-Alpha Bio, and how much has it raised?

Members of Seattle Flow see A-Alpha Bio's funding rounds, amounts and investors on its Funding tab. Joining is free.

Where is A-Alpha Bio based?

A-Alpha Bio is based in Seattle.

When was A-Alpha Bio founded?

A-Alpha Bio was founded in 2017.